SLN

#2241
Silence Therapeutics Plc American Depository Share
5.44
+1.30%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
5.44
5.44
Yıllık aralık
1.97
7.78
Günlük değişim
+1.30%
Aylık değişim
+5.84%
6 aylık değişim
+4.02%
Yıllık değişim
+15.74%
Önceki kapanış
5.37
Open
5.44
Bid
Ask
Low
5.44
High
5.44
Hacim
6
Open full chart

Financials

Overview Rapor Statistics Dividends
Quarterly Annual
  • Market Capitalization 770.81 M
  • Employee 116
  • Founded 1994
  • CEO Craig A Tooman
  • Website www.silence-therapeutics.com
  • Headquarter United Kingdom
  • FIGI BBG00WVTHPN2
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-11.28
Price to sales ratio
27.89
Dividends per share
—
Dividend yield %
—

Silence Therapeutics Plc - American Depository Share

Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London.

Haberler